Literature DB >> 7814279

Management of antibiotic-resistant pneumococcal infections.

K P Klugman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814279     DOI: 10.1093/jac/34.2.191

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  10 in total

1.  Multidrug-resistant Pathogens: Mechanisms of Resistance and Epidemiology.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

2.  In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae.

Authors:  E O Mason; L B Lamberth; S L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

3.  Bactericidal activities of ceftizoxime and cefotaxime against Streptococcus pneumoniae.

Authors:  K B Waites; T Rivers
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

Review 4.  Antimicrobial resistance in developing countries.

Authors:  C A Hart; S Kariuki
Journal:  BMJ       Date:  1998-09-05

Review 5.  Epidemiology, control and treatment of multiresistant pneumococci.

Authors:  K P Klugman
Journal:  Drugs       Date:  1996       Impact factor: 9.546

6.  In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia.

Authors:  P Urbásková; J Trupl; H Hupková; P C Appelbaum; M R Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-08       Impact factor: 3.267

7.  Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone.

Authors:  M Skulnick; G W Small; P Lo; M P Patel; C R Porter; D E Low; S Matsumura; T Mazzulli
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

Review 8.  Penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Emerging treatment for an emerging problem.

Authors:  K P Klugman; C Feldman
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

9.  Antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Lesotho.

Authors:  M Mthwalo; A Wasas; R Huebner; H J Koornhof; K P Klugman
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

10.  Pharmacokinetics of a new oral formulation of amoxicillin.

Authors:  M H Prevot; F Jehl; B Rouveix
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jan-Mar       Impact factor: 2.569

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.